(Left to right) Dr Magnus Nicolson, COO; Richard Boyd, CEO; Eric Beard, Chairman; Dr Andy Herbert, CTO; James Robson, CFO £5.3 million financing to complete First-in-Man safety study Led by Mercia, Downing Ventures, Old College Capital, Scottish Enterprise and Solvay Ventures; welcomes new investors Calculus...
We are Pioneer Group portfolio company, Rinri Therapeutics (‘Rinri’), is delighted to announce that it has secured, a grant from Innovate UK, the UK’s innovation agency. This grant will fund a £3.2 million project to further develop Rinri’s novel stem cell therapy to reverse sensorineural...
Image source: European Pharmaceutical Review GW’s ground-breaking medicines development programme recognised for outstanding achievement in innovation with UK’s highest official award for British business Based at Kent Science Park, GW Pharmaceuticals, a world leader in discovering, developing and commercialising regulatory approved cannabis-based medicines, announces that it has...
In4Derm announces a strategic partnership with an innovation-driven NASDAQ listed biotech with a >$200m Option License Agreement for first-in-class BET bromodomain therapeutics pipeline. In4Derm, an innovative biotech company developing novel therapeutics for inflammation and orphan indications, has today announced an Option and Licensing Agreement based around...
Integrated drug discovery and pre-clinical solutions provider, Sygnature Discovery, has appointed Dr. David Lustig to the role of Vice President Business Development - United States. Dr. Lustig will play a crucial role in the company’s US expansion, following the opening of Sygnature’s second US office...
BioAscent, the UK's fastest-growing integrated drug discovery CRO, has appointed Dr Angelo Pugliese as Associate Director of In Silico Discovery and Data Analysis to lead the company's computational chemistry service. As well as enhanced computational chemistry capabilities, the medicinal chemistry team has also been strengthened...
New owners We Are Pioneer Group have ambitious plans for the park and the wider UK life sciences sector Life sciences park Cardiff Edge is under new ownership with plans for significant expansion. The 27-acre scheme, located close to junction 32 of the M4 in north Cardiff,...
Sygnature Discovery, a world-leading integrated discovery and pre-clinical solutions provider, has established a new office presence in South San Francisco’s biotech hub at Oyster Point, where it can better serve current and future clients on the US west coast. The new office presence comes in the...
We Are Pioneer Group has been formed by merging existing accelerators BioCity and Knowledge Factory with Trinity, a property firm The £120m across two deals acquiring BioCity and a Cardiff science park will create a £450m business covering nine locations - 2.6 million...
Formation of We Are Pioneer Group, a new company borne from merger of BioCity and Knowledge Factory, creates a new integrated business combining early-stage life science investing and accelerator programme with real estate investment platform managing 2.6 million square feet of labs We...